New task order for university of oklahoma - study 9 maternal vaccination role of antitoxin under IDIQ contract HHSF223201210008I, entitled, "evaluation of pertussis pathogenesis and vaccine…
Ended Awarded Last action
- Contract number
- HHSF22301004T
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $266,240
Award facts
- Contract value 100% obligated
- $266,240.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $116,514 | |
| Original award | $149,726 |
About this award
This federal contract award is for a new task order under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract between the Food and Drug Administration (FDA) and the University of Oklahoma (OU) for a study on the role of antitoxin in maternal vaccination against pertussis using the baboon model. The award ceiling is $266,240.00 and the work will be performed in Oklahoma City, Oklahoma. The prime contractor is OU, and a subcontract was issued to the Texas Biomedical Research Institute for the purchase of baboons, laboratory procedures, and transportation. This contract does not have a set-aside designation. The overall IDIQ contract, titled "Evaluation of Pertussis Pathogenesis and Vaccine Effectiveness Using the Baboon Model of Pertussis Disease," supports the FDA's efforts to better understand pertussis disease and the effectiveness of pertussis vaccines.
Description
New task order for university of oklahoma - study 9 maternal vaccination role of antitoxin under IDIQ contract HHSF223201210008I, entitled, "evaluation of pertussis pathogenesis and vaccine effectiveness using the baboon model of pertussis disease"
Quick answers
Who was awarded contract HHSF22301004T?
HHSF22301004T was awarded to University Of Oklahoma by Food and Drug Administration (Department of Health and Human Services) on June 24, 2015.
How much is contract HHSF22301004T worth?
The government has obligated $266,240 on HHSF22301004T.
Is contract HHSF22301004T an order under another contract?
Yes. HHSF22301004T is a delivery order under HHSF223201210008I, an indefinite delivery contract.
Was contract HHSF22301004T competed?
The extent of competition for HHSF22301004T was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award